6 min. Read

Senate bill mentions DTx. Pear lobbying. FDA vs payers.

Issue 022.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a lucky 77 percent open rate. Here's what's happening this week:

  • Excited to announce that these past seven days were E&O's best week ever for new subscribers! Thanks to all the current readers who have encouraged colleagues to sign up. If you are new here: Feel free to reply to this newsletter to send feedback my way. Don't be shy, it makes this better for everyone.
  • Seed investor Rock Health announced that funding for digital health startups slowed down in Q3, which saw $1.3 billion flowing into the sector after two quarters that averaged $2 billion each. Current funding for the year stands at more than $5.5 billion.
  • Meanwhile, the digital health moon shooters over at StartUp Health have tracked $10.4 billion in digital health funding so far this year. They did,

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Facebook’s RCT for AI bot Zenny. More trials
7 min. Read
FDA de novo for Google smartphone thermometer.
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
8 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
6 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
8 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
5 min. Read
CPT decisions. Trials: Big Health, Mahana and more
6 min. Read
Akili CEO steps down. Aetna rolls back some virtual care coverage
5 min. Read
Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.
6 min. Read
  • First
  • Previous
  • 1 of 20
  • Next
  • Last